These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 7992699)

  • 1. [Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens].
    Shimizu T; Suzuki T; Yamanaka H; Satoh J; Suzuki K
    Hinyokika Kiyo; 1994 Oct; 40(10):869-72. PubMed ID: 7992699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M; Burgel JS; Serre I; Guiter J; Grasset D
    Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens].
    Plante P; Lesourd A; Blanchet P; Castagnola C; Coloby P; Daffer N; Davin JL; Desgrandchamps F; Irani J; Marechal JM; Mottet N; Pariente JL
    Prog Urol; 1998 Feb; 8(1):47-50. PubMed ID: 9533151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens.
    Stein JP; Cote RJ; Freeman JA; Esrig D; Elmajian DA; Groshen S; Skinner EC; Boyd SD; Lieskovsky G; Skinner DG
    J Urol; 1995 Oct; 154(4):1329-33. PubMed ID: 7658531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
    Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
    BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study.
    Maralani S; Wood DP; Grignon D; Banerjee M; Sakr W; Pontes JE
    Urology; 1997 Oct; 50(4):537-41. PubMed ID: 9338728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.
    Chen ME; Pisters LL; Malpica A; Pettaway CA; Dinney CP
    J Urol; 1997 Jun; 157(6):2120-3. PubMed ID: 9146596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
    Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G
    Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
    Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
    Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females.
    Kochakarn W; Chaimuangraj S; Leenanupunth C; Muangman V
    J Med Assoc Thai; 2001 Jun; 84(6):889-92. PubMed ID: 11556471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.